A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection

• Main Authors: Eugène D.M.B. Kroon (Author), Jintanat Ananworanich (Author), Amélie Pagliuzza (Author), Ajantha Rhodes (Author), Nittaya Phanuphak (Author), Lydie Trautmann (Author), Julie L. Mitchell (Author), Michelle Chintanaphol (Author), Jintana Intasan (Author), Suteeraporn Pinyakorn (Author), Khuntalee Benjapornpong (Author), J. Judy Chang (Author), Donn J. Colby (Author), Nitiya Chomchey (Author), James L.K. Fletcher (Author), Keith Eubanks (Author), Hua Yang (Author), John Kapson (Author), Ashanti Dantanarayana (Author), Surekha Tennakoon (Author), Robert J. Gorelick (Author), Frank Maldarelli (Author), Merlin L. Robb (Author), Jerome H. Kim (Author), Serena Spudich (Author), Nicolas Chomont (Author), Praphan Phanuphak (Author), Sharon R. Lewin (Author), Mark S. de Souza (Author)
• Format: Book
• Published: Elsevier, 2020-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective and Design: A randomized, open-label pilot study in individuals treated with antiretroviral therapy (ART) since acute HIV infection (AHI) with a regimen including a histone deacetylase inhibitor to induce HIV from latency and control HIV replication during subsequent treatment interruption...